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ABSTRACT
We have developed the Weighted Gene Expression
Tool and database (WeGET, http://weget.cmbi.umcn.
nl) for the prediction of new genes of a molecular sys-
tem by correlated gene expression. WeGET utilizes
a compendium of 465 human and 560 murine gene
expression datasets that have been collected from
multiple tissues under a wide range of experimental
conditions. It exploits this abundance of expression
data by assigning a high weight to datasets in which
the known genes of a molecular system are harmo-
niously up- and down-regulated. WeGET ranks new
candidate genes by calculating their weighted co-
expression with that system. A weighted rank is cal-
culated for human genes and their mouse orthologs.
Then, an integrated gene rank and p-value is com-
puted using a rank-order statistic. We applied our
method to predict novel genes that have a high de-
gree of co-expression with Gene Ontology terms and
pathways from KEGG and Reactome. For each query
set we provide a list of predicted novel genes, com-
puted weights for transcription datasets used and
cell and tissue types that contributed to the final
predictions. The performance for each query set is
assessed by 10-fold cross-validation. Finally, users
can use the WeGET to predict novel genes that co-
express with a custom query set.
INTRODUCTION
Ever since the publication of the first gene expression ar-
rays, the correlated expression of genes involved in a related
molecular process has been used to predict functional re-
lations between gene pairs (1). Large amounts of microar-
ray and RNA-seq transcript expression, measured under a
plethora of conditions enable mining for concordantly ex-
pressed genes. Indeed, this concept has been successfully
employed in databases such as COEXPRESSdb, Gene-
Friends, GeneMANIA and STARNET 2 (2–5). Neverthe-
less, relative to other types of genomics data, co-expression
has lower sensitivity and selectivity (6). To improve the qual-
ity of the predictions, various strategies have been applied,
like exploiting the conservation of co-expression between
species (7), combining many gene expression datasets (8,9)
or biclustering datasets to identify groups of genes that co-
express within a subset of the experiments (see (10) for a
review). Expression screening, an extension of biclustering
methods (11), weighs gene expression datasets based on the
co-expression of genes within a molecular system and uses
those weights to predict new genes involved in that system.
It has been successfully applied to predict new mitochon-
drial proteins essential for the organelle (11) and to discover
new players in heme biosynthesis (12). The principle behind
this method is appealing: it systematically exploits the avail-
able gene expression data and, via its weighting scheme, im-
plicitly solves the question facing many researchers: which
gene expression data to use to predict new genes for a
pathway? Nevertheless, it is computationally costly, as the
weighting has to be recalculated for each pathway sepa-
rately and additional cross validation requires multiple runs
per pathway.We have therefore developed and implemented
a fast expression screening algorithm that includes a dataset
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Figure 1. WeGET computational pipeline used to create the database. (A) Determining the dataset weight wdataset. The transcriptome measurements are
converted into a correlation matrix. The average correlation with the query set (sgene) is used for gene ranking and the dataset weight calculation wdataset.
(B) Data integration across datasets, platforms and species. Gene scores sgene from all datasets are combined taking into account the precomputed weights.
Subsequently different transcriptome platforms and species data are integrated to arrive at the final ranking. The process is repeated after excluding each
query gene to construct a receiver operating characteristic (ROC) curve that visualizes predictive power of the method for a specific query set of genes.
weighting and allows for the rapid computation of genes
that co-regulate with a query gene set. Our algorithm was
employed to compile a weighted co-expression database for
all Gene Ontology (GO) terms and human pathways anno-
tated in the KEGG and Reactome databases. Furthermore,
we provide information regarding the original experimental
setup of the highly weighted datasets. In particular, WeGet
reports the cell and tissue types in which the query genes
are consistently up- and down-regulated with each other.
Finally, the robustness of the predicted results is assessed
by 10-fold cross-validation and reported as the receiver op-
erating characteristic (ROC) curve.
We compared WeGET with five popular web tools and
databases that predict novel genes based on their co-
expression with specified query gene sets, using two query
gene sets published by Baughman et al. (ref 11) and show
that indeed, weighting the datasets results in improved pre-
cision, in particular at low recall rates (the top 100 genes).
The complete WeGET database, together with a custom
query submission system, is available through the WeGET
website.
THE WeGET ANALYSIS PIPELINE
WeGET uses a compendium of 465 human and 560 murine
gene expression datasets ranging from 6 to 192 samples
per dataset. In total, ∼30 000 samples from multiple mam-
malian platforms were collected from the Gene Expression
Omnibus (GEO) (13).
TheWeGET computational pipeline starts with selecting
the normalized expression values for all probes associated
with the query genes. For genes with multiple probes, the
probe with the highest average Pearson correlation coeffi-
cient with all other query probes is selected. Subsequently,
the pipeline calculates the average Pearson correlation be-
tween each gene and the set of query genes in every dataset
(Figure 1). Then, all probes are ranked based on their aver-
age correlation with the query probes and mapped back to
their associated gene. Each gene i obtains a score si depend-
ing on the fraction of the query set that has been ranked
above that gene. These calculations are then repeated four
times for the same query set and gene expression dataset,
where the expression values have been randomly permuted
between the genes in every measurement. This step esti-
mates the number of genes that are expected to highly corre-
late with the query set in a random model. To calculate the
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Figure 2. ROCperformance curves for online co-expression tools (see Sup-
plementaryTable SI1). Performancemeasured bymultiple cross-validation
runs is indicated by the area under the curve (AUC) for the top 100 genes
corresponding to a typical use case scenario. (A) Results for 19 genes in
the cholesterol pathway using leave-one-out cross-validation. (B) Results
for 10-fold cross-validation in the oxidative phosphorylation (OXPHOS)
query set.
Figure 3. The WeGET system architecture. Results for predefined path-
ways (GO, KEGG and Reactome) are precomputed and exposed through
the WeGET webtool. Custom defined gene sets can be analyzed by sub-
mitting the gene ids or gene symbols to the webserver.
dataset weight, an N100 value is calculated that is the frac-
tion of query genes found among the top 100 genes with
highest average Pearson correlation. The ratio between the
N100 from the original dataset and the average N100 value
for the randomized datasets constitutes the weight of the
experiments. A species score is the weighted average of all
its datasets. The final ranked gene list is obtained by inte-
grating the ranked human and mouse list (mouse genes that
are unambiguous human one-to-one orthologs). This is per-
formed using the RobustRankAggreg R-package (14) that
computes the final gene rankings using a rank-order statis-
tic (15,16).
Thus for each set of expression data the pipeline mea-
sures whether genes in a given pathway are co-expressed
with each other better than expected and uses that to assign
weights to that expression dataset. These weights are subse-
quently used in determining the (weighted) co-expression of
all genes with that pathway. The source of the variation in
the weights between the datasets can be technical, e.g. vari-
ation in the probes that have been used, or biological, e.g.
variation in the tissues in which gene expression has been
measured. The important assumption behind the method is
that new genes for a pathway are significantly co-expressed
with the majority of the genes of a pathway that they be-
long to, rather than only with some of its members. This, in
turn, depends on the pathway definition. To aid in finding
the genes from a pathway that co-express with each other,
the results include a visualization of co-expression between
query genes displayed as a network. This allows the user to
select a subset of co-expressed genes from that pathway to
repeat the procedure.
WeGET VALIDATION AND COMPARISON TO OTHER
CO-EXPRESSION DATABASES
To assess and compare the predictive power of different
co-expression methods (see Supplementary Table SI1), we
used two query gene sets (11): 19 query genes in the choles-
terol biosynthesis pathway and 76 genes involved in oxida-
tive phosphorylation (OXPHOS). We manually performed
leave-one-out or 10-fold cross validation by multiple sub-
missions (see SupplementaryMethods for details). We took
into account the top 100 ranked genes as a likely use case
scenario. Figure 2 shows the WeGET results for the choles-
terol biosynthesis pathway andOXPHOS system compared
to other online tools employing the co-expression analysis.
Baughman et al. (11) carried out one-time computations
for cholesterol and OXPHOS datasets. The Weget web-
server achieves identical (cholesterol) or marginally better
performance (OXPHOS, 86.4% sensitivity at 99.8% speci-
ficity, compared to 85% and 99.4%, respectively, see Sup-
plementary Figure SI1).
THE WeGET DATABASE AND WEB ACCESS
Figure 3 depicts the architecture of the WeGET database.
Human pathways and their associated genes from GO and
KEGG are stored in a central database. The WeGET par-
allel algorithm that calculates each dataset on a separate
thread precomputes the co-expressed genes and dataset
weights for all pathways using the transcriptome com-
pendium. The results are presented to the user using the
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Figure 4. The GO data grid. Users can browse or search the list of Gene Ontology (GO) terms. When a row is clicked, detailed information is provided
(see Figure 5). KEGG and Reactome pathways can be accessed in a similar fashion.
Figure 5. Detailed information for a precomputed term/pathway. The query genes, co-expressed genes, dataset weights and cross-validation results are
shown.
WeGET webtool (implemented in Python Flask) and can
additionally be downloaded.
On the WeGET website, pathways are shown in a data
grid (Figure 4), which can be sorted and searched. De-
tailed information (Figure 5), such as the best scoring genes,
dataset weights, cell and tissue types in which the genes
highly co-express (see also Supplementary Figures SI2 and
SI3) and cross-validation results are shown when a row
entry is selected. A pathway can be accessed directly as
weget.cmbi.umcn.nl/pathwaydb/identifier where pathwaydb
denotes the pathway database (one of: GO, KEGG or Re-
actome) and identifier the category identification (e.g. http:
//weget.cmbi.umcn.nl/GO/GO:0000398). User queries (dif-
ferent than the predefined sets) can be entered using the
‘Custom pathway’ tab, specifying genes as Entrez ID or
HUGOgene symbol. The query is then scheduled for analy-
sis. After the analysis, the user receives an email with results,
including the cross-validation and a network that displays
the co-regulation of the query genes within the datasets (see
below), in a spreadsheet.
The website provides an opportunity to learn more about
the experimental conditions in which the concordant ex-
pression of the query molecular system has been observed.
The tab ‘Dataset Weights’ accessible for each precomputed
Nucleic Acids Research, 2016, Vol. 44, Database issue D571
Table 1. Genes implicated in neuropathic pain collected from the literature.
No. Gene Symbol Sub-system No. Gene Symbol Sub-system
1 ACTG1 CORE 11 DPYSL2 TAG
2 ANK3 CORE 12 KCNK3 TAG
3 SCN10A CORE 13 NRCAM TAG
4 SCN11A CORE 14 ANXA2 TAG
5 SCN1B CORE 15 PRKACA TAG
6 SCN2B CORE 16 PRKCB TAG
7 SCN3A CORE 17 SYN2 TAG
8 SCN3B CORE 18 TNR TAG
9 SCN8A CORE 19 MSN PI
10 SPTBN4 CORE 20 NEDD4L PI
Core molecular sub-system associated with voltage-gated sodium channels (CORE), trafficking-associated genes (TAG) and the peripheral involvement
(PI) classes are indicated (23–25).
Table 2. Results from custom molecular system as received by the user. Top 40 genes prioritized for their involvement in neuropathic pain are shown.
Genes that were part of the query set are shown on shaded background.
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Figure 6. Visualization of performance of the WeGET results for neuropathic pain genes. (A) ROC curves for the neuropathic pain query set (Table 1).
The X axis represents fraction of human genes, the Y axis the fraction of the neuropathic pain molecular system. Shown are ROC curves for final results
(blue), the cross-validation (CV) of integrated datasets (green), the average co-expression across all datasets (integration with equal contribution of each
dataset) with CV (red) and results of co-expression within a single high-weight dataset (GDS1634, a nodose and dorsal root ganglia comparison, cyan)
(22). (B) Network visualization of the co-expression allows identification of genes less co-expressed with the core of the query set.
query set lists GEOdataset records with concordant expres-
sion patterns of the query system, indicating congruent co-
expression of the gene components of themolecular system.
The dataset identifier is directly hyperlinked with the GEO
entry description (both online and in Excel output file) such
that users can read details of the experiment that lead to
harmonious expression of the query set.
EVALUATION OF WeGET RESULTS FOR A QUERY
SET
The robustness of the results is tested by k-fold cross-
validation and graphically displayed with a ROC curve. The
curve illustrates the performance of theWeGETmethod, by
plotting the true positive rate (successfully cross-validated
query genes) versus all human genes (Figure 6). The curve
is plotted for every molecular system stored in the database
(GO, KEGG and Reactome pathways) separately. The area
under the curve (AUC) is a measure of the prediction qual-
ity and robustness for that pathway. The average AUC
computed for all pathways is around 0.7. Well-studied and
clearly defined cellular components such as mitochondria
and biological processes such as cilium movement and as-
sembly have a higher AUC (average 0.83 and 0.84, respec-
tively) reflecting their concordant expression patterns. For
pathwayswith less than 50 genes we use leave-one-out cross-
validation, for larger pathways 10-fold cross-validation is
carried out.
Finally, the cohesion of the query gene set is displayed as
a network using a node-force algorithm (Figure 6B). Query
genes that consistently co-express perform a large attractive
force and therefore cluster together. In contrast, genes that
show little evidence of co-regulation exhibit a smaller force
and do not cluster with the other query genes. Using this
visualization, the user can resubmit the query gene set to
omit genes that do not show evidence of co-regulation.
USING WeGET TO PREDICT GENES INVOLVED IN
NEUROPATHIC PAIN
Previous studies indicate that mutations in genes coding for
voltage-gated sodium channels and related processes may
impair the nociceptive pathway and influence response to
pain stimuli (17). From the literature we collected genes im-
plicated in neuropathic pain (Table 1) and used theWeGET
database to predict novel candidate genes for this pathway.
Table 2 shows genes co-expressing with the neuropathic
pain molecular system as calculated by WeGET. Next to
sodium channels and its regulators (PRMT8, UNC80 rank
41 and 74, respectively) also genes of the voltage-gated
potassium system are strongly represented among top co-
expressing genes (MAP1A, PPP2R2C, KCNH3, KCNQ2
rank 6, 7, 66 and 87, respectively) consistent with their in-
volvement in nociceptive processing (18), their expression
in dorsal root ganglion neurons analogous to voltage-gated
sodium channels (19) and with recently discovered genetic
variants that modulate neuropathic pain (20). The PIEZO2
gene, a nociceptive component mechanically activated in
nerve endings (21) ranks 74th among all genes. Additional
poorly characterized genes such as SERP2, TMEM130 and
CCDC155 (ranks 5, 9 and 20, respectively) are also present
among genes co-expressing with the system and constitute
novel candidate genes for nociceptive pathway. Figure 6A
shows the higher performance of WeGET integration of
all datasets (cross-validated AUC = 0.82) compared to in-
tegration of all datasets with equal weights (average co-
expression across all experiments, AUC = 0.71) and a high-
weight individual dataset GDS1634 of dorsal root ganglia
neurons (AUC = 0.68). Weights assigned to GEO datasets
reveal a high contribution of transcriptome measurements
related to neurons: a murine nodose and dorsal root gan-
glia study (GDS1634, weight 3.0) (22), gene expression in
human neurofibrillary tangles (GDS2795, weight 2.5) and
DNA methylation effect on neural stem cells (GDS538,
weight 3.0). The peripheral roles of DPYSL2 (trafficking
subset, Table 1), MSN and NEDD4L proteins (peripheral
Nucleic Acids Research, 2016, Vol. 44, Database issue D573
subclass) are visualized in the query gene network (Figure
6B). Currently we screen patients with a familial form of
neuropathic pain for genetic variants that may impact the
function of the candidate genes.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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